Document is current

Any future updates will be listed below

Correction to: Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT

Crossref DOI link: https://doi.org/10.1186/s13075-020-02238-4

Published Online: 2020-06-09

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark